Dan Lenihan

Jan 8, 2025 | radcliffecardiology.com | Joe Carver |Dan Lenihan

Faculty: Overview Join Dr Joe Carver (University of Pennsylvania, US) and Dr Dan Lenihan (Saint Francis Healthcare System, US) as they discuss complex clinical scenarios at the intersection of heart disease and cancer treatment. This session will provide essential insights into the latest approaches to managing cardiac complications in cancer patients, including novel therapies, diagnostic challenges and risk mitigation strategies.

Nov 7, 2024 | radcliffecardiology.com | Mazyar Shadman |Dan Lenihan |Joe Carver

Faculty: Overview Join Dr Mazyar Shadman(University of Washington, US), Dr Dan Lenihan (Saint Francis Healthcare System, US) and Dr Joe Carver (University of Pennsylvania, US) as they explore the latest advancements and challenges in managing cardiovascular manifestations in patients undergoing targeted therapies like Bruton's Tyrosine Kinase (BTK) inhibitors, Chimeric Antigen Receptor T-cell (CAR-T) therapies and cutting-edge immunotherapies.

Oct 1, 2024 | radcliffecardiology.com | Jose A. Alvarez-Cardona |Dan Lenihan |Joe Carver

Overview Join Dr Rohan Bhandari (Washington University, St Louis, US), Dr Jose Alvarez-Cardona (New York University School of Medicine, US), Dr Dan Lenihan (Saint Francis Healthcare System, US) and Dr Joe Carver (University of Pennsylvania, US) for this month's Journal Club where faculty will tackle critical research in the developing field of cardio-oncology. Learn about the safety and tolerability profiles of Zanubrutinib and Ibrutinib in patients with B-cell malignancies.

Sep 9, 2024 | radcliffecardiology.com | Dan Lenihan |Joe Carver

Faculty: Overview Join Dr Jeff Sharman (US Oncology & Sarah Cannon Research Institute Network, US), Dr Dan Lenihan (Saint Francis Healthcare System, US) and Dr Joe Carver (University of Pennsylvania, US) for an in-depth exploration of Bruton Tyrosine Kinase (BTK) inhibitors and their impact on cardiovascular health. This session will delve into cutting-edge research, clinical applications and emerging insights on how BTK inhibitors influence heart function.

Aug 2, 2024 | radcliffecardiology.com | Dan Lenihan |Joe Carver |Hetan Shah

Faculty: Overview Join Dr Hetan C Shah (Seth GS Medical College and King Edward Memorial Hospital, IN), Dr Dan Lenihan (Saint Francis Healthcare System, US) and Dr Joe Carver (University of Pennsylvania, US) for an insightful webinar on Immune Checkpoint Inhibitors-Related Myocarditis. This essential session will delve into the complexities of myocarditis associated with immune checkpoint inhibitors, exploring the latest research, clinical challenges, and management strategies.